Cargando…

Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication

BACKGROUND: With the development of whole-genome sequencing technology, non-invasive prenatal testing (NIPT) has been applied gradually to screen chromosomal microdeletions and microduplications that cannot be detected by traditional karyotyping. However, in NIPT, some false positives and false nega...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Weifang, Yuan, Yangyang, Yuan, Erfeng, Zhang, Linlin, Liu, Ling, Li, Ying, Guo, Jing, Cui, Xueyin, Li, Pengyun, Cui, Shihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466692/
https://www.ncbi.nlm.nih.gov/pubmed/37644576
http://dx.doi.org/10.1186/s40001-023-01285-2
_version_ 1785098943816794112
author Tian, Weifang
Yuan, Yangyang
Yuan, Erfeng
Zhang, Linlin
Liu, Ling
Li, Ying
Guo, Jing
Cui, Xueyin
Li, Pengyun
Cui, Shihong
author_facet Tian, Weifang
Yuan, Yangyang
Yuan, Erfeng
Zhang, Linlin
Liu, Ling
Li, Ying
Guo, Jing
Cui, Xueyin
Li, Pengyun
Cui, Shihong
author_sort Tian, Weifang
collection PubMed
description BACKGROUND: With the development of whole-genome sequencing technology, non-invasive prenatal testing (NIPT) has been applied gradually to screen chromosomal microdeletions and microduplications that cannot be detected by traditional karyotyping. However, in NIPT, some false positives and false negatives occur. This study aimed to investigate the applicability of extended NIPT (NIPT-PLUS) in the detection of chromosomal aneuploidy and microdeletion/microduplication syndrome (MMS). METHODS: A total of 452 pregnancies that underwent prenatal diagnostic testing (amniocentesis or chorionic villus sampling) by chromosomal microarray analysis (CMA), were screened by NIPT-PLUS from the peripheral blood sample of the pregnant women. The results of the two tested items were compared and analysed. RESULTS: Of the 452 cases, 335 (74.12%) had positive CMA results, and 117 (25.88%) had no abnormal results. A total of 86 cases of trisomy 21, 18 and 13 and sex chromosome aneuploidy (SCA) were detected by CMA and NIPT-PLUS, with a detection rate of 96.51% (83/86). Among them, the detection rates of T18, T13; 47, XXY; 47, XXX and 47 XYY were 100%, and the detection rates of T21 and 45 XO were 96.55% and 90%, respectively. The detection sensitivity of rare chromosomal trisomy (RAT) was 80% (4/5). The positive predictive values of NIPT-PLUS for chromosome aneuploidy T21, T18 and T13 and for SCA and RAT were 90.32%, 87.50%, 25.00%, 88.89% and 50%, respectively. A total of 249 cases (74.32%) of chromosomal MMS were detected by CMA. The detection rate of NIPT-PLUS was 63.86% (159/249), and 90 cases (36.14%) were missed. The larger the MMS fragment, the higher the NIPT-PLUS detection sensitivity. In addition, most small fragments were of maternal origin. CONCLUSION: The comparison between the CMA and NIPT-PLUS techniques shows that NIPT-PLUS has high sensitivity for detecting chromosomal aneuploidy and chromosomal copy number variations (CNVs) with fragments > 5 M. However, the sensitivity of CNV for fragments < 5 M is low, and the missed detection rate is high. Additionally, confined placental mosaicism and foetal mosaicism are the key factors causing false negatives in NIPT-PLUS, while maternal chromosomal abnormalities and confined placental mosaicism are key contributors to false positives, so appropriate genetic counselling is especially important for pregnant women before and after NIPT-PLUS testing.
format Online
Article
Text
id pubmed-10466692
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104666922023-08-31 Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication Tian, Weifang Yuan, Yangyang Yuan, Erfeng Zhang, Linlin Liu, Ling Li, Ying Guo, Jing Cui, Xueyin Li, Pengyun Cui, Shihong Eur J Med Res Research BACKGROUND: With the development of whole-genome sequencing technology, non-invasive prenatal testing (NIPT) has been applied gradually to screen chromosomal microdeletions and microduplications that cannot be detected by traditional karyotyping. However, in NIPT, some false positives and false negatives occur. This study aimed to investigate the applicability of extended NIPT (NIPT-PLUS) in the detection of chromosomal aneuploidy and microdeletion/microduplication syndrome (MMS). METHODS: A total of 452 pregnancies that underwent prenatal diagnostic testing (amniocentesis or chorionic villus sampling) by chromosomal microarray analysis (CMA), were screened by NIPT-PLUS from the peripheral blood sample of the pregnant women. The results of the two tested items were compared and analysed. RESULTS: Of the 452 cases, 335 (74.12%) had positive CMA results, and 117 (25.88%) had no abnormal results. A total of 86 cases of trisomy 21, 18 and 13 and sex chromosome aneuploidy (SCA) were detected by CMA and NIPT-PLUS, with a detection rate of 96.51% (83/86). Among them, the detection rates of T18, T13; 47, XXY; 47, XXX and 47 XYY were 100%, and the detection rates of T21 and 45 XO were 96.55% and 90%, respectively. The detection sensitivity of rare chromosomal trisomy (RAT) was 80% (4/5). The positive predictive values of NIPT-PLUS for chromosome aneuploidy T21, T18 and T13 and for SCA and RAT were 90.32%, 87.50%, 25.00%, 88.89% and 50%, respectively. A total of 249 cases (74.32%) of chromosomal MMS were detected by CMA. The detection rate of NIPT-PLUS was 63.86% (159/249), and 90 cases (36.14%) were missed. The larger the MMS fragment, the higher the NIPT-PLUS detection sensitivity. In addition, most small fragments were of maternal origin. CONCLUSION: The comparison between the CMA and NIPT-PLUS techniques shows that NIPT-PLUS has high sensitivity for detecting chromosomal aneuploidy and chromosomal copy number variations (CNVs) with fragments > 5 M. However, the sensitivity of CNV for fragments < 5 M is low, and the missed detection rate is high. Additionally, confined placental mosaicism and foetal mosaicism are the key factors causing false negatives in NIPT-PLUS, while maternal chromosomal abnormalities and confined placental mosaicism are key contributors to false positives, so appropriate genetic counselling is especially important for pregnant women before and after NIPT-PLUS testing. BioMed Central 2023-08-30 /pmc/articles/PMC10466692/ /pubmed/37644576 http://dx.doi.org/10.1186/s40001-023-01285-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tian, Weifang
Yuan, Yangyang
Yuan, Erfeng
Zhang, Linlin
Liu, Ling
Li, Ying
Guo, Jing
Cui, Xueyin
Li, Pengyun
Cui, Shihong
Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication
title Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication
title_full Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication
title_fullStr Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication
title_full_unstemmed Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication
title_short Evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication
title_sort evaluation of the clinical utility of extended non-invasive prenatal testing in the detection of chromosomal aneuploidy and microdeletion/microduplication
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466692/
https://www.ncbi.nlm.nih.gov/pubmed/37644576
http://dx.doi.org/10.1186/s40001-023-01285-2
work_keys_str_mv AT tianweifang evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication
AT yuanyangyang evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication
AT yuanerfeng evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication
AT zhanglinlin evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication
AT liuling evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication
AT liying evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication
AT guojing evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication
AT cuixueyin evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication
AT lipengyun evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication
AT cuishihong evaluationoftheclinicalutilityofextendednoninvasiveprenataltestinginthedetectionofchromosomalaneuploidyandmicrodeletionmicroduplication